SEC Considering Responses to Issuer Retaliation Against Analysts
In case you missed the article below, BNA is reporting that the SEC is considering possible rulemaking or modification of SRO listing standards to address reports of retaliation against analysts by issuers and VC fund investors for unfavorable analyst reports.
SEC Is Weighing Possible Action
To Address Retaliation Against Analysts
The Securities and Exchange Commission is considering whether to act to address the problem of issuer retaliation against research analysts for unfavorable reports, Chairman Christopher Cox said in a Sept. 1 letter to Sen. Ron Wyden (D-Ore.)
"This is indeed a concern and we will tackle it," Cox said in the letter, which Wyden's office provided to BNA Sept. 23.
With the letter, Cox forwarded an Aug. 23 SEC staff memo from SEC Deputy Director of the Division of Market Regulation Robert Colby detailing industry feedback on issuer retaliation. The memo said that the staff is weighing whether to recommend an SEC rulemaking or modification of self-regulatory organization listing standards to combat the problem.
Firms Report Retaliation
Of the nine firms surveyed by the staff, six believed that issuer retaliation is an ongoing concern and provided specific examples. The firms, which were not named, observed that retaliatory conduct by companies is often subtle.
According to the staff memo, among the types of retaliation reported by the six firms were:
- limitations on participation in company organized conference calls or events;
- restricted access to senior management;
- threats by senior executives to withdraw business from the firm of an analyst who has maintained unfavorable ratings or price targets;
- criticism of the analyst's work product on conference calls and in the media; and
- threats by company management of legal action alleging defamation as a result of statements made in a research report.
Finally, "[s]everal firms," the staff said, "reported increased pressure and retaliation by venture capital firms holding pre-IPO [initial public offering] shares of an issuer and the possibility that the analyst's firm may not be selected as the investment bank for the deal if the analyst is not optimistic about the transaction."
Some of the surveyed firms suggested that formal regulatory action likely was not a practical solution to the problem, the staff said.
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.